Brainpower boosted by tapping out a specific rhythm, study finds The rhythm method: Not just what you tap, but how often, seems to have the biggest impact on hearing Depositphotos ...

The last time I wrote about Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) it was in a Seeking Alpha article entitled "Rhythm: Upcoming sNDA Label Expansion IMCIVREE Isn't The Only Catalyst On Deck." ...

Rhythm Pharmaceuticals, Inc. (RYTM) shares ended the last trading session 17.1% higher at $54.96. The jump came on an impressive volume with a higher-than-average number of shares changing hands ...

This can be a common problem for those who exercise first thing in the morning. A heart arrhythmia is an abnormal heartbeat. It may cause the heart to beat too quickly, too slowly, or irregularly.

While pharma giants Novo Nordisk and Eli Lilly may have a solid hold on the obesity arena, Rhythm Pharmaceuticals is looking to corner a subset of the market with its Imcivree. About 5,000 to ...

Stifel analysts were bullish on the data, which showed a 16.5% drop in body-mass index among patients with damage to the hypothalamus taking Rhythm Pharmaceuticals’ Imcivree. Rhythm Pharmaceuticals’ ...

Seizure-related cardiac arrhythmias are frequently reported and have been implicated as potential pathomechanisms of Sudden Unexpected Death in Epilepsy (SUDEP). We attempted to identify clinical ...

PFA was noninferior to cryoablation for first recurrence of atrial tachyarrhythmia in patients with paroxysmal atrial ... the residual burden of atrial arrhythmia is increasingly recognized ...

ECG classification using MIT-BIH data, a deep CNN learning implementation of Cardiologist-level arrhythmia detection and classification in ambulatory ...

Artificial intelligence (AI) is paving the way for advancements in cardiology, with researchers now able to identify patients at risk of severe arrhythmias that could trigger cardiac arrest and sudden ...

PFA was noninferior to cryoballoon ablation and was associated with a lower recurrence rate of atrial arrhythmia at 1 year among patients with symptomatic paroxysmal atrial fibrillation.